longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Flora Growth

FLGC

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.72, within the reasonable range, cheaper than 52.19% of the time in the past 5 years, and the industry ranks 27/54, the industry Median -0.30.

-0.719xP/E
--Stock price
-0.719xP/E
Stock price--

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.72x
Typical range
-1.27x–-0.32x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
04896144192

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
SSDOYUSShiseido
-65.36x--$8.57B
COTYUSCoty
-3.75x115.33%$2.32B
EPCUSEdgewell Personal Care
-13.29x85.53%$1.24B
GLASUSGlass House Brands
-11.74x--$752.06M
HNSTUSHonest
-46.84x166.37%$569.68M
USNAUSUSANA Health Sciences
-12.36x205.17%$274.01M
YSGUSYatsen
-8.11x34.23%$243.89M
NUSUSNu Skin
-1.10x248.43%$237.54M
WALDUSWaldencast
-0.74x65.17%$170.59M
MEDUSMedifast
-5.26x44.71%$134.73M
SKINUSSkinHealth
-3.16x8.39%$89.80M
UPXIUSUpexi
-0.30x--$69.32M
BHSTUSBioHarvest Sciences
-3.83x12.08%$42.39M
DSYUSBig Tree Cloud
----$18.10M
MTEXUSMannatech
-2.22x--$16.42M
ZIVOUSZivo Bioscience
-1.76x--$14.95M
NHTCUSNatural Health Trend
-8.40x--$13.64M
HYEXUSHealthy Extracts Inc.
-15.10x--$13.27M
NAIIUSNatural Alternatives
-0.88x--$12.68M
CABRUSCaring Brands
-1.20x--$11.82M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.